e-Drug3D 509 |
OXYMETAZOLINE
|
cas 1491-59-4 |
CLASS RESPIRATORY SYSTEM |
ROUTE (list) OPHTHALMIC NASAL TOPICAL |
PK parameters |
Target TARGET ALPHA-2A ADRENERGIC RECEPTOR ALPHA-1A ADRENERGIC RECEPTOR PDB Ligand code = J5C (link to the list of PDB complexes) Download experimental 3D coordinates of J5C with added hydrogens |
DrugCentral Alpha-1A adrenergic receptor UNIPROT P35348 ADRA1A Alpha-2B adrenergic receptor UNIPROT P18089 ADRA2B |
Download SDF file | 6-tert-butyl-3-(4,5-dihydro-1H-imidazol-2-ylmethyl)-2,4-dimethylphenol Formula: Calculated chemical properties: MW 260.37 NB_atoms 19 XLogP 2.85 PSA 40.388 NB_HD 2 NB_HA 3 fsp3 0.56 Lipinski(0=no;1=yes) 1 |
FDA NDA 018471 (pdf not found) INN (OXYMETAZOLINE HYDROCHLORIDE) OCUCLEAR (BAYER HEALTHCARE LLC) APPROVAL= AP YEAR= 1986 DISCONTINUED NDA 019407 (pdf not found) INN (OXYMETAZOLINE HYDROCHLORIDE) VISINE L.R. (KENVUE BRANDS) APPROVAL= AP YEAR= 1989 NDA 208032 (pdf not found) INN (OXYMETAZOLINE HYDROCHLORIDE ; TETRACAINE HYDROCHLORIDE) KOVANAZE (ST RENATUS) APPROVAL= AP YEAR= 2016 NDA 208552 (pdf not found) INN (OXYMETAZOLINE HYDROCHLORIDE) RHOFADE (MAYNE PHARMA) APPROVAL= AP YEAR= 2017 NEWAPPLICATION NDA 212520 (pdf not found) INN (OXYMETAZOLINE HYDROCHLORIDE) UPNEEQ (RVL PHARMS) APPROVAL= AP YEAR= 2020 NDA 213584 (pdf not found) INN (OXYMETAZOLINE HYDROCHLORIDE) OXYMETAZOLINE HYDROCHLORIDE (TARO) APPROVAL= AP YEAR= 2021 DISCONTINUED NDA 211812 (pdf not found) INN (OXYMETAZOLINE) OXYMETAZOLINE (TEVA PHARMS USA INC) APPROVAL= TA YEAR= 2022 |
Other links: |